Skip to Content

AstraZeneca COVID-19 Vaccine Trial Restarts

MONDAY, Sept. 14, 2020 -- Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.

"The independent review process has concluded and following the recommendations of both the independent safety review committee and the U.K. regulator … the trials will recommence in the U.K.," the university said in a statement released on Saturday. No further details were given on the results of the review.

Media reports have said the person who had the suspected adverse reaction had been volunteering in a trial based in the United Kingdom. The volunteer was diagnosed with transverse myelitis. The university said in large trials, "it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety." Globally, some 18,000 people have received the vaccine so far, the Associated Press reported.

The AstraZeneca vaccine is considered a front-runner among the dozens of COVID-19 vaccines in various stages of testing around the world, the AP reported.

AP News Article

© 2020 HealthDay. All rights reserved.

Posted: September 2020

Read this next

More Than Half of Pregnant Women With COVID-19 Asymptomatic

FRIDAY, Sept. 18, 2020 -- More than half of hospitalized pregnant women with COVID-19 are asymptomatic at admission, while pregnant women hospitalized for COVID-19-related illness have...

Lower Proportion of Inpatients With COVID-19 Wear Glasses

FRIDAY, Sept. 18, 2020 -- The proportion of inpatients with COVID-19 who wear eyeglasses for extended daily periods is lower than in the general population, according to a study published...

Older Adults Experiencing More Loneliness During Pandemic

FRIDAY, Sept. 18, 2020 -- Older adults are feeling more isolated during the COVID-19 pandemic, according to a report published online Sept. 14 based on the results of the University...